Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proseq Cancer: A Prospective Study of Comprehensive Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

NCT05695638 is registered in ClinicalTrials.gov with Morten Ladekarl as lead sponsor.

NCT NCT05695638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05695638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proseq Cancer: A Prospective Study of Comprehensive Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment
Lead sponsor
Morten Ladekarl
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2020
Completion date
May 31, 2035
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haematological malignancy, solid tumor, unspecified, adult